A Letter From Our CEO
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
Calvin Goforth, PhD
Recent Posts
Should Life Science Investors Invest in the Horse or the Jockey?
When considering early-stage investment opportunities, many investors emphasize the team over the business opportunity, i.e., they bet on the jockey more than the horse. However, in the realm of life science startup...
Navigating Investment Opportunities in Medical Devices: A Guide for Savvy Investors
In the ever-evolving healthcare landscape, technological innovations continue to drive significant advancements. In this article, we delve into the realm of medical device investment, exploring key trends,...
A Letter from our CEO
In the past year, we saw great achievements across our portfolio of high-impact life science companies despite a challenging overall fundraising environment. Our VIC Tech team and the portfolio company teams showed...
The Genomic Revolution: Unveiling Personalized Medicine's Investment Potential
In healthcare, a paradigm shift is underway – one that promises to transform healthcare as we know it. The emergence of personalized medicine, fueled by groundbreaking advancements in genomics and diagnostics, can save...
FDA Breakthrough Device Designation for High Impact Medical Devices
Within the VIC Tech portfolio, SFC Fluidics and Solenic Medical have both announced FDA Breakthrough Device designation. But what is FDA Breakthrough Device designation and what benefits does it provide? From a...
The Advantages of Investing in Venture Creation Firms Like VIC Tech
In the world of early stage investing, traditional venture capital funds have long been the go-to option for investors seeking exposure to high-growth opportunity companies. However, a different investment model is...
Due Diligence for Life Science Investments
Investing in a life science startup can be a lucrative opportunity, but it requires careful evaluation to weigh the potential reward against the level of risk. Members of VIC Tech's affiliated VIC Investor Network...
A Letter from our CEO
As CEO of VIC Tech, I am fortunate to have the opportunity to review exciting new life science technologies on an ongoing basis and regularly speak with life science thought leaders, inventors, investors, and large...
Our Life Science and Healthcare Future
Dramatic life science advancements are emerging that are likely to transform healthcare over the next 20 years. For example, continued rapid progress of cell and gene therapies will offer a complete cure for a wide...
